A comparison of safety and immunogenicity between government of India approved Rabies pre exposure prophylaxis regimen and WHO Rabies pre exposure prophylaxis regime
Phase 3
- Registration Number
- CTRI/2023/09/057399
- Lead Sponsor
- Dr N R Ramesh Masthi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
•Healthy subjects willing to volunteer and sign written informed consent for the study.
•Subjects should be available for the follow-up period.
Exclusion Criteria
?Received Anti rabies vaccine or RIG or RMAb anytime in the past.
?Participation in any other clinical trial in the past three months.
?Severely immunocompromised subjects, pregnant and lactating women.
Subjects with known history of allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method